First Trust Capital Management
CPRX icon

First Trust Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

First Trust Capital Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-416,209
Closed -$13.1M – 191
2026
Q2 		$13.1M Buy
+416,209
New +$12.3M 0.76% 17

Other funds holding CPRX

Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

First Trust Capital Management's CPRX Position: Q3 2026 in Review

First Trust Capital Management sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 416,209 shares — an estimated $13.1M sold.

First Trust Capital Management first reported a position in CPRX in Q2 2026 and held it in 1 quarter. The position peaked at $13.1M in Q2 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.

  • First Trust Capital Management reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • First Trust Capital Management sold 416,209 Catalyst Pharmaceutical shares in Q3 2026, an estimated $13.1M.
  • First Trust Capital Management first reported a position in Catalyst Pharmaceutical in Q2 2026 and held it in 1 quarter.
  • First Trust Capital Management's Catalyst Pharmaceutical position peaked at $13.1M in Q2 2026.
  • 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on First Trust Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.